An, Seong Beom http://orcid.org/0000-0001-6020-7642
Yang, Bo-Gie http://orcid.org/0000-0002-1538-8488
Jang, Gyeonghui
Kim, Do-Yeon
Kim, Jiyoung
Oh, Sung-Man
Oh, Nahyun
Lee, Sanghee
Moon, Ji-Yeong
Kim, Jeong-Ah
Kim, Ji-Hyun
Song, Yoo-Jeong
Hyun, Hye-Won
Kim, Jisoo
Lee, Kyungwha
Lee, Dajeong
Kwak, Min-Jung
Kim, Byung Kwon http://orcid.org/0000-0002-3937-8049
Park, Young-Kyu http://orcid.org/0000-0001-8283-7813
Hong, Chun-Pyo
Kim, Jung Hwan
Lim, Hye Seong
Ryu, Min Sook
Jin, Hyun-Tak
Lee, Seung-Woo
Chang, Yoon-Seok
Park, Hae-Sim http://orcid.org/0000-0003-2614-0303
Sung, Young Chul http://orcid.org/0000-0003-2726-907X
Jang, Myoung Ho http://orcid.org/0000-0001-8909-4725
Funding for this research was provided by:
Rural Development Administration (PJ01331901, PJ01131601)
Ministry of Health and Welfare (HR16C0001)
Article History
Received: 15 July 2020
Accepted: 6 September 2022
First Online: 27 September 2022
Competing interests
: Y.C.S. and M.H.J. are inventors on patents related to this work (PCT/KR2019/000270 & PCT/KR2019/000524). Authors affiliated with GI Innovation Inc., GI Biome Inc., GI Cell Inc. and ProGen Inc. are employees of the respective companies, which are involved in the co-development of IgE<sub>TRAP</sub> and <i>Bifidobacterium longum</i> combination therapy for IgE-mediated food allergy. Y.-S.C. and H.-S.P. are consultants for GI Innovation. The remaining authors declare no competing financial and non-financial interests.